Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | RGS12 | O14924 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34460906 | 0.93 | TERT (0.87) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL6234260 | 0.93 | TERT (0.87) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| Iodide SCHEMBL6230746 | 0.92 | TERT (0.84) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| Iodide SCHEMBL6232922 | 0.91 | TERT (0.82) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL29322636 | 0.91 | TERT (0.82) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL22506215 | 0.89 | TERT (0.79) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL34460911 | 0.85 | TERT (0.73) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL2196672 | 0.85 | CHRM2 (0.75) | TERTKMT2AMEN1CYP1A2CHRM2 | |
| SCHEMBL21367403 | 0.82 | TERT (1.00) | TERTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL16558634 | 0.82 | TERT (0.86) | TERTKMT2AMEN1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119153803-B | Quick-charge and quick-discharge lithium battery and preparation method thereof | 赣州旭航诚新能源有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118364594-B | Numerical simulation method for rapidly extruding multiple air columns by water flow in up-down fluctuation pipeline | 河海大学 | 2024-12-24 | — | — | CN | claimed |
| CN-119153803-A | Quick-charge and quick-discharge lithium battery and preparation method thereof | 赣州旭航诚新能源有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118364594-A | Numerical simulation method for rapidly extruding multiple air columns by water flow in up-down fluctuation pipeline | 河海大学 | 2024-07-19 | — | — | CN | claimed |
| CN-117414424-A | Preparation method of photosensitizer based on naphthalene dianhydride small molecule | 浙江工业大学 | 2024-01-19 | — | — | CN | claimed |
| EP-4109163-A1 | OPTICAL SYSTEM, CAMERA MODULE, ELECTRONIC DEVICE AND AUTOMOBILE | TIANJIN OFILM OPTO ELECTRONICS CO., LTD (CN) | 2022-12-28 | — | — | EP | claimed |
| CN-114600522-A | Information processing method, terminal equipment and network equipment | 华为技术有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-116643381-B | Imaging lens system | SAMSUNG ELECTRO-MECHANICS CO.,LTD. (KR) | 2026-05-26 | — | — | CN | disclosed |
| CN-116643382-B | Imaging lens system | SAMSUNG ELECTRO-MECHANICS CO.,LTD. (KR) | 2026-05-26 | — | — | CN | disclosed |
| EP-4723530-A1 | DATA TRANSMISSION METHOD AND APPARATUS, AND TERMINAL AND NETWORK DEVICE | Datang Mobile Communications Equipment Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| EP-4714062-A1 | WIRELESS COMMUNICATION METHOD AND RELATED PRODUCTS | Huawei Technologies Co., Ltd. (CN) | 2026-03-25 | — | — | EP | disclosed |
| US-20260000645-A1 | USE OF EBSELEN OR ONE OF THE DERIVATIVES THEREOF TO TREAT MITOCHONDRIAL PATHOLOGIES OR DYSFUNCTIONS | ASS FRANCAISE CONTRE LES MYOPATHIES (FR) | 2026-01-01 | — | — | US | disclosed |
| US-20260003163-A1 | IMAGING LENS SYSTEM | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2026-01-01 | — | — | US | disclosed |
| CN-114609758-A | Imaging lens system | 三星电机株式会社 | 2022-06-10 | — | — | CN | disclosed |
| CN-114600522-A | Information processing method, terminal equipment and network equipment | 华为技术有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114586428-A | Resource transmission method and terminal equipment | OPPO广东移动通信有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114424490-A | Group-based acknowledgement feedback for wireless communications in the presence of semi-persistent scheduling | 高通股份有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20220066170-A1 | IMAGING LENS SYSTEM | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2022-03-03 | — | — | US | disclosed |
| CN-114114611-A | Imaging lens system | 三星电机株式会社 | 2022-03-01 | — | — | CN | disclosed |
| WO-2022018297-A1 | USE OF ALVERINE OR ITS DERIVATIVES FOR THE TREATMENT OF MITOCHONDRIAL DISEASES OR DYSFUNCTION ASSOCIATED WITH MITOCHONDRIAL COMPLEX I DEFICIENCIES | ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES (FR) | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260003163-A1 | IMAGING LENS SYSTEM | INCENP, CRYZ, INF2 | TERT 2229/4885KMT2A 4246/4885MEN1 755/4885 |
| US-20260000645-A1 | USE OF EBSELEN OR ONE OF THE DERIVATIVES THEREOF TO TREAT MITOCHONDRIAL PATHOLOGIES OR DYSFUNCTIONS | ERAL1, MT-CO3, GFM1 | TERT 674/4885KMT2A 4290/4885MEN1 1710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.